Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin vs TMP-SMX for uSSTI
NCT00730028Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2009
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clindamycin, trimethoprim + sulfamethoxazole in skin and soft tissue infection (SSTI), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2009; status: completed.
02
Drugs
clindamycintrimethoprim + sulfamethoxazole
03
Conditions
skin and soft tissue infection (SSTI)
Beyond the preview
Go deeper on NCT00730028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730028.